In glioma, a number of oncogenic landmarks have been identified previously, such as somatic alternations on IDH, O-6-methylguanine-DNA methyltransferase (MGMT) promoter, TERT promoter, and chromosome 1p/19q co-del (7, 68). This evidence concerns the gene MGMT and central nervous system cancer.